Analytical Data
-
基因名
TAGLN
- Application
-
别名
TAGLN；SM22；Transgelin
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q01995
-
表达区间
1-201aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMANKGPSYGMSREVQSKIEKKYDEELEERL VEWIIVQCGPDVGRPDRGRLGFQVWLKNGVILSKLVNSLYPDGSKPVKVP ENPPSMVFKQMEQVAQFLKAAEDYGVIKTDMFQTVDLFEGKDMAAVQRTL MALGSLAVTKNDGHYRGDPNWFMKKAQEHKREFTESQLQEGKHVIGLQMG SNRGASQAGMTGYGRPRQIIS
-
分子量
25 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human AMDHD2 Protein，GST
Cat：PA2000-5461
Recombinant Human OR52N5 Protein，His
Cat：PA2000-9971
Protein Description
Tropomyosin-1 (TAGLN), a member of the tropomyosin family, is an actin-binding protein that plays a crucial role in various cellular processes, such as cytoskeletal organization, cell migration, and signal transduction. Its expression is predominantly observed in smooth muscle cells and non-muscle cells, and it has been linked to several physiological and pathological processes, including development, cancer progression, and response to injury. Recent studies have highlighted TAGLN's involvement in regulating cell shape and motility, making it a potential target for therapeutic intervention in diseases characterized by abnormal cell behavior. Additionally, the reorganization of TAGLN can influence the remodeling of the extracellular matrix, further emphasizing its significance in cellular dynamics. Investigating the recombinant forms of TAGLN can provide insights into its structural and functional properties, enhancing our understanding of its role in health and disease. This background sets the stage for exploring TAGLN's potential as both a biomarker and a therapeutic target in various clinical contexts.
